Association between plaque thickness of the thoracic aorta and recurrence of atrial fibrillation after ablation

Korean Circulation Journal

Volumn 41, Issue 4, 2011, Pages 177-183

  Hwang, Hui Jeong ^a   Lee, Man Young ^a   Youn, Ho Joong ^a   Oh, Yong Seog ^a   Rho, Tae Ho ^a   Chung, Wook Sung ^a   Park, Chul Soo ^a   Choi, Yun Seok ^a   Chung, Woo Baek ^a   Lee, Jae Beom ^a   Park, Hyun Keun ^a   Lim, Keunjoon ^a   Lee, Jae Hak ^a  

^a The Catholic University of Korea College of Medicine   (South Korea)

Author keywords

Aorta; Atherosclerosis; Atrial fibrillation; Catheter ablation; Thoracic

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; ANTICOAGULANT AGENT; HEPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVERSION; CIRCUMFERENTIAL PULMONARY VEIN ABLATION; CLINICAL FEATURE; DIABETES MELLITUS; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE MARKER; DRUG HALF LIFE; FEMALE; HAZARD RATIO; HEART ATRIUM FIBRILLATION; HUMAN; ISCHEMIC HEART DISEASE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PULMONARY VEIN ISOLATION; RECURRENT DISEASE; RISK FACTOR; STROKE; THORACIC AORTA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY;

EID: 79957800442     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2011.41.4.177     Document Type: Article

References (30)

1. Wolf PA, Abbott RD, Kannel WB. Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991;22:983-8.
2. Benjamin EJ, Wolf PA, D'Agostino RB, Silbershatz H, Kannel WB, Levy D. Impact of atrial fibrillation on the risk of death: the Framingham Heart Study. Circulation 1998;98:946-52. (Pubitemid 28446646)
3. Wang TJ, Larson MG, Levy D, et al. Temporal relations of atrial fibrillation and congestive heart failure and their Joint influence on mortality: the Framingham Heart Study. Circulation 2003;107:2920-5. (Pubitemid 36736633)
4. Lee KS, Choi SJ, Park SH, Kim HL, Min H, Park HY. Prevalence of atrial fibrillation in middle-aged people in Korea: the Korean genome and epidemiology study. Korean Circ J 2008;38:601-5.
5. Sauer WH, McKernan ML, Lin D, Gerstenfeld EP, Callans DJ, Marchlinski FE. Clinical predictors and outcomes associated with acute return of pulmonary vein conduction during pulmonary vein isolation for treatment of atrial fibrillation. Heart Rhythm 2006;3:1024-8.
6. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 1995;155:469-73.
7. Benjamin EJ, Levy D, Vaziri SM, D'Agostino RB, Belanger AJ, Wolf PA. Independent risk factors for atrial fibrillation in a population-based cohort: the Framingham Heart Study. JAMA 1994;271:840-4.
8. Berruezo A, Tamborero D, Mont L, et al. Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J 2007;28:836-41. (Pubitemid 47343599)
9. Frost L, Hune LJ, Vestergaard P. Overweight and obesity as risk factors for atrial fibrillation or flutter: the Danish Diet, Cancer, and Health Study. Am J Med 2005;118:489-95. (Pubitemid 40615472)
10. Goto S, Bhatt DL, Rother J, et al. Prevalence, clinical profile, and cardiovascular outcomes of atrial fibrillation patients with atherothrombosis. Am Heart J 2008;156:855-63.
11. Heeringa J, van der Kuip DA, Hofman A, et al. Subclinical atherosclerosis and risk of atrial fibrillation. Arch Intern Med 2007;167:382-7. (Pubitemid 46333939)
12. Blackshear JL, Pearce LA, Hart RG, et al. Aortic plaque in atrial fibrillation: prevalence, predictors, and thromboembolic implications. Stroke 1999;30:834-40. (Pubitemid 29156377)
13. Agmon Y, Khandheria BK, Meissner I, et al. Association of atrial fibrillation and aortic atherosclerosis: A population-based study. Mayo Clin Proc 2001;76:252-9. (Pubitemid 32206938)
14. De Potter T, Berruezo A, Mont L, et al. Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation. Europace 2010;12:24-9.
15. Cappato R, Calkins H, Chen SA, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation 2005;111:1100-5. (Pubitemid 40365469)
16. Chen MS, Marrouche NF, Khaykin Y, et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol 2004;43:1004-9. (Pubitemid 38352980)
17. Fuster V, Rydén LE, Cannom DS, et al. ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation. Circulation 2006;114:e257-354.
18. Calvo N, Mont L, Tamborero D, et al. Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes. Europace 2010;12:30-6.
19. Natale A, Raviele A, Arentz T, et al. Venice chart international consensus document on atrial fibrillation ablation. J Cardiovasc Electrophysiol 2007;18:560-80. (Pubitemid 46650353)
20. Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiography in atrial fibrillation: standards for acquisition and interpretation and assessment of interobserver variability. J Am Soc Echocardiogr 1996;9:556-66.
21. Amarenco P, Cohen A, Tzourio C, et al. Atherosclerotic disease of the aortic arch and the risk of ischemic stroke. N Engl J Med 1994;331:1474-9. (Pubitemid 24356305)
22. Otto CM. Textbook of Clinical Echocardiography. 4th ed. Philadelphia: WB. Saunders Company; 2009. p. 125-56.
23. Casaclang-Verzosa G, Gersh BJ, Tsang TS. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. JAm Coll Cardiol 2008;51:1-11.
24. Hwang GS, Kim YH, Kim MK, et al. Gene expression and ultrastructural remodeling in persistent atrial fibrillation. Korean Circ J 2004;34:693-705.
25. Park JH, Oh YS, Kim JH, et al. Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on patients following ablation of atrial fibrillation. Korean Circ J 2009;39:185-9.
26. Oakes RS, Badger TJ, Kholmovski EG, et al. Detection and quantification of left arterial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation 2009;119:1758-67.
27. Boisvert WA, Rose DM, Boullier RA, et al. Leukocyte transglutaminase 2 expression limits atherosclerotic lesion size. Arterioscler Thromb Vasc Biol 2006;26:563-9.
28. Machey RH, Venkitachalam L, Sutton-Tyrrell K. Calcifications, arterial stiffness and atherosclerosis. Adv Cardiol 2007;44:234-44.
29. Cheema A, Vasamreddy CR, Dalai D, et al. Long-term single procedure efficacy of catheter ablation of atrial fibrillation. J Interv Card Electrophysiol 2006;15:145-55. (Pubitemid 44510957)
30. Hof I, Arbab-Zadeh A, Scherr D, et al. Correlation of left atrial diameter by echocardiography and left atrial volume by computed tomography. J Cardiovasc Electrophysiol 2009;20:159-63.